Nuclear Receptors in Myocardial and Cerebral Ischemia—Mechanisms of Action and Therapeutic Strategies
Nearly 18 million people died from cardiovascular diseases in 2019, of these 85% were due to heart attack and stroke. The available therapies although efficacious, have narrow therapeutic window and long list of contraindications. Therefore, there is still an urgent need to find novel molecular targ...
Enregistré dans:
Auteurs principaux: | Joanna Rzemieniec, Laura Castiglioni, Paolo Gelosa, Majeda Muluhie, Benedetta Mercuriali, Luigi Sironi |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/456adc5bcc2d44569d80c0c2bc32130f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
PPARα Modulation-Based Therapy in Central Nervous System Diseases
par: Deokho Lee, et autres
Publié: (2021) -
Lipedema and the Potential Role of Estrogen in Excessive Adipose Tissue Accumulation
par: Kaleigh Katzer, et autres
Publié: (2021) - PPAR research
-
Tryptophan Metabolism Activates Aryl Hydrocarbon Receptor-Mediated Pathway To Promote HIV-1 Infection and Reactivation
par: Yan-Heng Zhou, et autres
Publié: (2019) -
Aryl Hydrocarbon Receptors in Indole Derivative Treated Mice: Neuropharmacological Perspectives
par: Andreeva-Gateva P., et autres
Publié: (2021)